CorVel (NASDAQ:CRVL) Full Year 2025 Results

Key Financial Results

Revenue: US$895.6m (up 13% from FY 2024). Net income: US$95.2m (up 25% from FY 2024). Profit margin: 11% (up from 9.6% in FY 2024). The increase in margin was driven by higher revenue. EPS: US$1.85 (up from US$1.48 in FY 2024).

We check all companies for important risks. See what we found for CorVel in our free report.NasdaqGS:CRVL Revenue and Expenses Breakdown May 24th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

In the last 12 months, the only revenue segment was Managed Care contributing US$895.6m. Notably, cost of sales worth US$685.9m amounted to 77% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$88.9m (78% of total expenses). Explore how CRVL's revenue and expenses shape its earnings.

CorVel shares are down 2.9% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on CorVel's balance sheet health.

Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

View Comments